Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The main objective of the study is to evaluate the patient preference for pain treatment with
respect to quality of life in patients with moderate to severe non malignant pain. Patients
who have insufficient pain relief and/or unacceptable side effects with the previous
analgesic treatment WHO step 1 or 2 and require around-the-clock opioid therapy can be
included in the study. The WHO step I or II analgesics will be compared with the new study
medication OXN (oxycodone/naloxone).